Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Enhancement of the therapeutic outcome of radio-immunotherapy by combination with whole-body mild hyperthermia
Immunotherapy of multiple myeloma
Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy
[Addition of hyperthermia. Heat potentiates cancer therapy]
The use of dendritic cells in cancer therapy
The role of heat shock protein (hsp70) in dendritic cell maturation: hsp70 induces the maturation of immature dendritic cells but reduces DC differentiation from monocyte precursors
Antitumor effects of Newcastle Disease Virus in vivo: local versus systemic effects
Localised spontaneous regression in mesothelioma — possible immunological mechanism
Preliminary results of active specific immunization with modified tumor cell vaccine in glioblastoma multiforme
Dendritic cells for specific cancer immunotherapy
Generation of hepatitis C virus-specific cytotoxic T lymphocytes from healthy individuals with peptide-pulsed dendritic cells
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming
Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration
Posttreatment histology and microcirculation status of osteogenic sarcoma after a neoadjuvant chemo- and radiotherapy in combination with local electromagnetic hyperthermia
Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide
Effect of hyperthermia on AKR lymphoma variants differing in degree of malignancy
Dendritic cells and chronic hepatitis virus carriers
Dendritic cells derived from multiple myeloma patients efficiently internalize different classes of myeloma protein
In vitro induction of a bladder cancer-specific T-cell response by mRNA-transfected dendritic cells
Treatment of a patient by vaccination with autologous dendritic cells pulsed with allogeneic major histocompatibility complex class I-matched tumor peptides. Case Report